🇺🇸 FDA
Pipeline program

Placebo

CMUH102-REC2-011

Approved other active

Quick answer

Placebo for Gastroesophageal Reflux Disease is a Approved program (other) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Gastroesophageal Reflux Disease
Phase
Approved
Modality
other
Status
active

Clinical trials